Strategic Choices in the Age of AI: Shaping the Future of Life Sciences explores how artificial intelligence is fundamentally transforming the life sciences and medtech industry not just by accelerating discovery but also by reshaping how value is created, delivered and captured. As AI removes long-standing constraints in research, the bottleneck is shifting downstream to development, evidence generation and real-world impact. At the same time, new digital interfaces and data ecosystems are redefining how patients access care and how decisions are made.
Drawing on insights from senior industry leaders and global analysis, the report outlines the strategic choices organizations must make to remain competitive in this new landscape. It also highlights the growing importance of public-private alignment, as regulation, reimbursement and data governance increasingly shape which innovations can scale.
It provides practical guidance to actively shape the future of life sciences to succeed as a commercial enterprise while delivering better health outcomes and contributing to the sustainability of healthcare systems.